CTFA challenges FDA analysis of consumer AHA adverse events -- CIR meeting.
This article was originally published in The Rose Sheet
CTFA DISPUTES FDA ANALYSIS OF CONSUMER AHA ADVERSE REACTION REPORTS at the March 5 meeting of the Cosmetic Ingredient Review Expert Panel in Washington, D.C. At the meeting, non-voting industry liaison Gerald McEwen, VP-science at the Cosmetic, Toiletry, and Fragrance Association, questioned the FDA statistic that for every cosmetic adverse reaction reported by a consumer to FDA, 50-100 are reported to manufacturers. "FDA has frequently over the years known things that I've been unable to find any validation for...this is probably one of those," McEwen asserted. "I submit the data does not support that," he concluded
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review